Cargando…

Design of a trans protease lentiviral packaging system that produces high titer virus

BACKGROUND: The structural and enzymatic proteins of the human immunodeficiency virus (HIV) are initially generated as two long polyproteins encoded from overlapping reading frames, one producing the structural proteins (Gag) and the second producing both structural and enzymatic proteins (Gag-Pol)....

Descripción completa

Detalles Bibliográficos
Autores principales: Westerman, Karen A, Ao, Zhujun, Cohen, Éric A, Leboulch, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259377/
https://www.ncbi.nlm.nih.gov/pubmed/18163907
http://dx.doi.org/10.1186/1742-4690-4-96
_version_ 1782151386120585216
author Westerman, Karen A
Ao, Zhujun
Cohen, Éric A
Leboulch, Philippe
author_facet Westerman, Karen A
Ao, Zhujun
Cohen, Éric A
Leboulch, Philippe
author_sort Westerman, Karen A
collection PubMed
description BACKGROUND: The structural and enzymatic proteins of the human immunodeficiency virus (HIV) are initially generated as two long polyproteins encoded from overlapping reading frames, one producing the structural proteins (Gag) and the second producing both structural and enzymatic proteins (Gag-Pol). The Gag to Gag-Pol ratio is critical for the proper assembly and maturation of viral particles. To minimize the risk of producing a replication competent lentivirus (RCL), we developed a "super-split" lentiviral packaging system in which Gag was separated from Pol with minimal loss of transducibility by supplying protease (PR) in trans independently of both Gag and Pol. RESULTS: In developing this "super-split" packaging system, we incorporated several new safety features that include removing the Gag/Gag-Pol frameshift, splitting the Gag, PR, and reverse transcriptase/integrase (RT/IN) functions onto separate plasmids, and greatly reducing the nucleotide sequence overlap between vector and Gag and between Gag and Pol. As part of the construction of this novel system, we used a truncated form of the accessory protein Vpr, which binds the P6 region of Gag, as a vehicle to deliver both PR and RT/IN as fusion proteins to the site of viral assembly and budding. We also replaced wt PR with a slightly less active T26S PR mutant in an effort to prevent premature processing and cytoxicity associated with wt PR. This novel "super-split" packaging system yielded lentiviral titers comparable to those generated by conventional lentiviral packaging where Gag-Pol is supplied intact (1.0 × 10(6 )TU/ml, unconcentrated). CONCLUSION: Here, we were able to create a true "split-function" lentiviral packaging system that has the potential to be used for gene therapy applications. This novel system incorporates many new safety features while maintaining high titers. In addition, because PR is supplied in trans, this unique system may also provide opportunities to examine viral protein processing and maturation.
format Text
id pubmed-2259377
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22593772008-03-04 Design of a trans protease lentiviral packaging system that produces high titer virus Westerman, Karen A Ao, Zhujun Cohen, Éric A Leboulch, Philippe Retrovirology Research BACKGROUND: The structural and enzymatic proteins of the human immunodeficiency virus (HIV) are initially generated as two long polyproteins encoded from overlapping reading frames, one producing the structural proteins (Gag) and the second producing both structural and enzymatic proteins (Gag-Pol). The Gag to Gag-Pol ratio is critical for the proper assembly and maturation of viral particles. To minimize the risk of producing a replication competent lentivirus (RCL), we developed a "super-split" lentiviral packaging system in which Gag was separated from Pol with minimal loss of transducibility by supplying protease (PR) in trans independently of both Gag and Pol. RESULTS: In developing this "super-split" packaging system, we incorporated several new safety features that include removing the Gag/Gag-Pol frameshift, splitting the Gag, PR, and reverse transcriptase/integrase (RT/IN) functions onto separate plasmids, and greatly reducing the nucleotide sequence overlap between vector and Gag and between Gag and Pol. As part of the construction of this novel system, we used a truncated form of the accessory protein Vpr, which binds the P6 region of Gag, as a vehicle to deliver both PR and RT/IN as fusion proteins to the site of viral assembly and budding. We also replaced wt PR with a slightly less active T26S PR mutant in an effort to prevent premature processing and cytoxicity associated with wt PR. This novel "super-split" packaging system yielded lentiviral titers comparable to those generated by conventional lentiviral packaging where Gag-Pol is supplied intact (1.0 × 10(6 )TU/ml, unconcentrated). CONCLUSION: Here, we were able to create a true "split-function" lentiviral packaging system that has the potential to be used for gene therapy applications. This novel system incorporates many new safety features while maintaining high titers. In addition, because PR is supplied in trans, this unique system may also provide opportunities to examine viral protein processing and maturation. BioMed Central 2007-12-28 /pmc/articles/PMC2259377/ /pubmed/18163907 http://dx.doi.org/10.1186/1742-4690-4-96 Text en Copyright © 2007 Westerman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Westerman, Karen A
Ao, Zhujun
Cohen, Éric A
Leboulch, Philippe
Design of a trans protease lentiviral packaging system that produces high titer virus
title Design of a trans protease lentiviral packaging system that produces high titer virus
title_full Design of a trans protease lentiviral packaging system that produces high titer virus
title_fullStr Design of a trans protease lentiviral packaging system that produces high titer virus
title_full_unstemmed Design of a trans protease lentiviral packaging system that produces high titer virus
title_short Design of a trans protease lentiviral packaging system that produces high titer virus
title_sort design of a trans protease lentiviral packaging system that produces high titer virus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259377/
https://www.ncbi.nlm.nih.gov/pubmed/18163907
http://dx.doi.org/10.1186/1742-4690-4-96
work_keys_str_mv AT westermankarena designofatransproteaselentiviralpackagingsystemthatproduceshightitervirus
AT aozhujun designofatransproteaselentiviralpackagingsystemthatproduceshightitervirus
AT cohenerica designofatransproteaselentiviralpackagingsystemthatproduceshightitervirus
AT leboulchphilippe designofatransproteaselentiviralpackagingsystemthatproduceshightitervirus